Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Common variable immunodeficiency. Review].

J Iglesias Alzueta1, N Matamoros Florí

  • 1Servicio de Inmunología, Hospital Son Dureta, Palma de Mallorca, España.

Allergologia Et Immunopathologia
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The Spanish Registry of Primary Immunodeficiencies (REDIP)].

Allergologia et immunopathologia·2001
Same author

[Primary immunodeficiencies. The current prospects in diagnosis and treatment].

Medicina clinica·2000
Same author

[Primary immunodeficiencies in Spain. Data of the Spanish Registry of Primary Immunodeficiencies. REDIP 1980-1999 (Registro Español de Immunodeficiencias Primarias)].

Medicina clinica·2000
Same author

[The Spanish Registry of Primary Immunodeficiencies. REDIP-1998].

Sangre·1999
Same author

CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.

Haematologica·1998
Same author

Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults.

Journal of clinical immunology·1997
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Gastrointestinal stenosis: an underrecognized complication of CARMIL2 deficiency.

Allergologia et immunopathologia·2026
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Vitamin B12 allergy and desensitization.

Allergologia et immunopathologia·2026
Same journal

Chronic HBV infection, stemness pathways, and compromised immune surveillance in HCC development.

Allergologia et immunopathologia·2026
Same journal

Application of FeNO in the diagnostic and therapeutic algorithm of pediatric asthma: From chronic cough and wheeze to personalized management.

Allergologia et immunopathologia·2026
See all related articles

Common variable immunodeficiency (CVI) is a primary immunodeficiency causing recurrent infections due to low antibody levels. Early diagnosis and gamma-globulin treatment significantly improve patient outcomes and life expectancy.

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Common variable immunodeficiency (CVI) is a primary immunodeficiency defined by impaired antibody production, leading to hypogammaglobulinemia.
  • The exact cause of CVI remains unknown, but in vitro studies reveal B cell defects, T cell abnormalities, and impaired accessory cell interactions.
  • A hallmark of CVI is the B lymphocyte differentiation failure, hindering immunoglobulin secretion and contributing to recurrent infections.

Purpose of the Study:

  • To elucidate the underlying cellular and molecular alterations in CVI.
  • To describe the diverse clinical manifestations and associated conditions in CVI patients.
  • To outline diagnostic criteria and effective treatment strategies for CVI.

Main Methods:

  • Review of in vitro studies detailing B cell, T cell, and accessory cell abnormalities.

Related Experiment Videos

  • Analysis of clinical data on infection patterns, autoimmune diseases, and malignancies in CVI patients.
  • Evaluation of diagnostic approaches, including exclusion of other conditions and key indicators like hypogammaglobulinemia.

    • Main Results:

    • Patients with CVI exhibit recurrent bacterial infections, particularly respiratory tract infections, and increased susceptibility to certain fungal, mycobacterial, and parasitic infections.
    • Associated conditions include autoimmune disorders (e.g., hemolytic anemia, ITP) and malignancies (e.g., non-Hodgkin's lymphoma).
    • Diagnosis relies on excluding other disorders and identifying serum hypogammaglobulinemia, with differential diagnosis considering X-linked agammaglobulinemia and autosomal recessive forms.

    Conclusions:

    • CVI is characterized by impaired B cell differentiation and function, leading to recurrent infections and increased risk of autoimmunity and cancer.
    • Early diagnosis, prompt antibiotic treatment for infections, and timely immunoglobulin replacement therapy are crucial for managing CVI.
    • Treatment with human gamma-globulin, typically administered intravenously, is the mainstay of CVI management, improving quality of life and life expectancy.